CIRM Funded Clinical Trials

SRN-101 AAV Immuno-Gene Therapy for High-Grade Glioma

Disease Area:
Brain Cancer
Investigator:
Dr Nicole K Paulk
Institution:
Siren Biotechnology, Inc.
CIRM Grant:
CLIN2-19526 (Pre-Active)
Award Value:
$7,999,774.00
Trial Sponsor:
Siren Biotechnology, Inc.
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A